Medidata Solutions launches EDC solution for Phase IV clinical trials
By on Jul 22, 2002
"Like most of our products, 4sight was conceived and designed in response to our customers' demands - in this case, providing a targeted solution for their phase IV and registry needs," said Glen de Vries, CTO. "We believe 4sight will become the EDC standard for the industry, setting the benchmark for value-added services required to be competitive in these trials," added Tarek Sherif, Chief Executive Officer.
Medidata 4sight is designed to leverage the company's TrialTek EDC platform capabilities, and deliver cost-per-page efficiencies. According to Medidata, branding and site compliance opportunities are driven via informational portal content and links, product newsletters, and competitive enrollment reports.